CN103524576A - Separation and purification process of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside - Google Patents
Separation and purification process of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside Download PDFInfo
- Publication number
- CN103524576A CN103524576A CN201310350567.7A CN201310350567A CN103524576A CN 103524576 A CN103524576 A CN 103524576A CN 201310350567 A CN201310350567 A CN 201310350567A CN 103524576 A CN103524576 A CN 103524576A
- Authority
- CN
- China
- Prior art keywords
- stilbene
- pure water
- extract
- stilbene glycoside
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000746 purification Methods 0.000 title claims abstract description 24
- 238000000926 separation method Methods 0.000 title claims abstract description 24
- JAYVHSBYKLLDJC-DSNJPTTOSA-N (E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C=C(O)C=C1\C=C\C1=CC=C(O)C=C1 JAYVHSBYKLLDJC-DSNJPTTOSA-N 0.000 title claims abstract description 5
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims abstract description 137
- 235000021286 stilbenes Nutrition 0.000 claims abstract description 137
- 229930182470 glycoside Natural products 0.000 claims abstract description 136
- -1 stilbene glycoside Chemical class 0.000 claims abstract description 136
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 83
- 239000000284 extract Substances 0.000 claims abstract description 52
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000741 silica gel Substances 0.000 claims abstract description 23
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 23
- 239000013078 crystal Substances 0.000 claims abstract description 17
- 239000011521 glass Substances 0.000 claims abstract description 16
- 238000002425 crystallisation Methods 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 230000008025 crystallization Effects 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 10
- 238000012546 transfer Methods 0.000 claims abstract description 9
- 238000001291 vacuum drying Methods 0.000 claims abstract 2
- 238000005303 weighing Methods 0.000 claims abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000007710 freezing Methods 0.000 claims description 18
- 230000008014 freezing Effects 0.000 claims description 18
- 238000005406 washing Methods 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000155 melt Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 18
- 238000009776 industrial production Methods 0.000 abstract description 3
- 239000003480 eluent Substances 0.000 abstract description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 abstract description 2
- 150000002338 glycosides Chemical class 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 24
- 238000004128 high performance liquid chromatography Methods 0.000 description 21
- 238000000967 suction filtration Methods 0.000 description 18
- 238000001514 detection method Methods 0.000 description 17
- 239000000843 powder Substances 0.000 description 14
- 241001289529 Fallopia multiflora Species 0.000 description 12
- 239000007787 solid Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000005070 sampling Methods 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003517 fume Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- 238000005377 adsorption chromatography Methods 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010262 high-speed countercurrent chromatography Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
Images
Landscapes
- Saccharide Compounds (AREA)
Abstract
本发明提供了2,3,5,4′-四羟基二苯乙烯-2-O-β-D-葡萄糖苷(以下简称“二苯乙烯苷”)的分离纯化工艺,通过称取二苯乙烯苷提取物经硅胶拌样呈松散状,置玻璃柱上面用洗脱剂洗脱,经过TLC跟踪检测,合并含有二苯乙烯苷的流份,回收溶剂,干燥得二苯乙烯苷的提取物,加纯水加热溶解二苯乙烯苷提取物后冷冻结晶,待其溶化后抽滤,并用纯水洗涤,可得类白色的结晶,将滤渣转移至真空干燥箱干燥,得到二苯乙烯苷纯品;该工艺操作简单可行,并可以提高产品纯度,能够快速大量地分离和纯化二苯乙烯苷;该工艺操作简便,成本低廉,收率稳定,在保持低成本和高收率的同时,经重结晶处理后能获得高纯度的二苯乙烯苷,适合规模化工业生产的需要。
The present invention provides a separation and purification process for 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside (hereinafter referred to as “stilbene glycoside”). By weighing stilbene The glycoside extract was mixed with silica gel in a loose form, placed on a glass column and eluted with an eluent, tracked and detected by TLC, combined the fractions containing stilbene glycosides, recovered the solvent, and dried to obtain the stilbene glycoside extract. Add pure water to heat to dissolve the stilbene glycoside extract, then freeze and crystallize it, after it dissolves, suction filter and wash with pure water to obtain off-white crystals, transfer the filter residue to a vacuum drying oven for drying, and obtain pure stilbene glycoside ; The process is simple and feasible to operate, and can improve product purity, and can quickly and massively separate and purify stilbene glycosides; the process is easy to operate, low in cost, and stable in yield. After the crystallization treatment, high-purity stilbene glycosides can be obtained, which is suitable for large-scale industrial production.
Description
技术领域 technical field
本发明涉及中药分离纯化技术领域,尤其是2,3,5,4′-四羟基二苯乙烯-2-O-β-D-葡萄糖苷(以下简称“二苯乙烯苷”)的分离纯化工艺。 The invention relates to the technical field of separation and purification of traditional Chinese medicine, especially the separation and purification process of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (hereinafter referred to as "stilbene glycoside") . the
背景技术 Background technique
何首乌,为蓼科植物何首乌Polygonum multiflorum Thunb.的干燥块根,始载于《开元本草》,分布于华东、中南及河北、山西、陕西、甘肃、台湾、四川、贵州、云南等地,具有解毒、消痈、润肠通便之功效,同时还具有补益精血、乌须发、强筋骨和补肝肾。药理研究表明何首乌具有抗衰老、提高机体非特异性免疫功能、降血脂、抗动脉粥样硬化、保护心肌、保肝、神经保护及抗菌等药理活性,临床研究主要用于治疗高脂血症,失眠症,白发,疖肿等。何首乌中的有效成分主要包括以大黄酚、大黄素、大黄酸、大黄素甲醚为主的蒽醌类成分及二苯乙烯苷,其中蒽醌类成分能解毒、消痈、润肠通便,而二苯乙烯苷具有明显的降低胆固醇和保肝作用。二苯乙烯苷是何首乌药材中的主要活性成分,《中华人民共和国药典》2010年版一部对二苯乙烯苷的总量限度作出明确规定,何首乌药材中二苯乙烯苷的总量不得少于1.0%。二苯乙烯苷是何首乌中具有重要药理作用的活性成分之一,临床应用及现代药理研究表明二苯乙烯苷具有显著的抗衰老及降脂作用。 Polygonum multiflorum is the dry tuberous root of Polygonum multiflorum Thunb., a Polygonum multiflorum Thunb. It was first recorded in "Kaiyuan Materia Medica". It has the effects of eliminating carbuncles, moistening the intestines and laxatives, and also has the functions of nourishing essence and blood, black beard and hair, strengthening muscles and bones, and nourishing the liver and kidney. Pharmacological studies have shown that Polygonum multiflorum has anti-aging, improving the body's non-specific immune function, lowering blood fat, anti-atherosclerosis, protecting the myocardium, protecting the liver, neuroprotection and antibacterial and other pharmacological activities. Clinical research is mainly used for the treatment of hyperlipidemia, insomnia syndrome, white hair, boils, etc. The active ingredients in Radix Polygoni Multiflori mainly include anthraquinones and stilbene glycosides mainly composed of chrysophanol, emodin, rhein, and emodin methyl ether. Among them, anthraquinones can detoxify, eliminate carbuncle, and laxative. The stilbene glycosides have obvious cholesterol-lowering and liver-protecting effects. The stilbene glycosides are the main active ingredients in Polygonum multiflorum. The 2010 edition of the Pharmacopoeia of the People's Republic of China clearly stipulates the total amount of stilbene glycosides. The total amount of stilbene glycosides in Polygonum multiflorum must not be less than 1.0 %. Stilbene glycoside is one of the active ingredients in Polygonum multiflorum with important pharmacological effects. Clinical application and modern pharmacological research have shown that stilbene glycoside has significant anti-aging and lipid-lowering effects. the
如何快速分离纯化大量的二苯乙烯苷是工业生产中密切关注的问题。目前关于二苯乙烯苷分离纯化的方法有结晶法、聚酰胺吸附色谱法、大孔树脂吸附色谱法、高速逆流色谱法等。 How to quickly separate and purify a large amount of stilbene glycosides is a problem of close concern in industrial production. At present, methods for the separation and purification of stilbene glycosides include crystallization, polyamide adsorption chromatography, macroporous resin adsorption chromatography, high-speed countercurrent chromatography, and the like. the
例如,结晶法是比较传统的提取方法,用95%乙醇回流提取何首乌粗粉,回收乙醇得何首乌流浸膏,用适量的蒸馏水稀释后以等量的乙醚萃取3次,水层用两倍的醋酸乙酯热回流5-6h,收集醋酸乙酯层,减压浓缩至原体积的 1/10,室温下静置析晶,过滤,得到二苯乙烯苷粗品。粗品于适量热水或热醋酸乙酯中溶解,趁热过滤,放冷析晶,如此反复结晶,得到二苯乙烯苷精品,为灰色无定形结晶粉末。经HPLC法分析,粗品中二苯乙烯苷纯度为68.71%,精品中为99.94%。该方法分离纯化得到的二苯乙烯苷纯度虽高,然而此法存在着溶剂用量大,工艺复杂,资源利用率偏低等缺点。 For example, the crystallization method is a relatively traditional extraction method. The coarse powder of Polygonum multiflorum is extracted with 95% ethanol under reflux, and the ethanol is recovered to obtain the liquid extract of Polygonum multiflorum, which is diluted with an appropriate amount of distilled water and extracted three times with an equal amount of ether. Ethyl acetate was refluxed for 5-6 hours, the ethyl acetate layer was collected, concentrated under reduced pressure to 1/10 of the original volume, left to stand at room temperature for crystallization, and filtered to obtain the crude stilbene glycoside. Dissolve the crude product in an appropriate amount of hot water or hot ethyl acetate, filter it while it is hot, let it cool and crystallize, and repeat the crystallization in this way to obtain the refined stilbene glycoside as a gray amorphous crystalline powder. According to HPLC analysis, the purity of stilbene glycosides in the crude product is 68.71%, and that in the fine product is 99.94%. Although the purity of the stilbene glycosides obtained by separation and purification by this method is high, there are still some disadvantages in this method, such as large amount of solvent used, complex process, and low utilization rate of resources. the
此外还有研究采用高效液相色谱法分离得到纯度较高的二苯乙烯苷单体,但是此方法仪器成本高,溶剂消耗量大,制约了该技术的发展。本领域需要有能够快速和(/或)大量地制备纯度较高的二苯乙烯苷的方法。 In addition, there are researches using high-performance liquid chromatography to separate stilbene glycoside monomers with high purity, but this method has high instrument cost and large solvent consumption, which restricts the development of this technology. There is a need in the art for a method capable of rapidly and/or mass-preparing stilbene glycosides with higher purity. the
发明内容 Contents of the invention
本发明所要解决的技术问题在于提供二苯乙烯苷的分离纯化工艺。 The technical problem to be solved by the present invention is to provide a separation and purification process for stilbene glycosides. the
为解决上述技术问题,本发明的技术方案是: For solving the problems of the technologies described above, technical scheme of the present invention is:
二苯乙烯苷的分离纯化工艺,具体步骤为:精密称量初步纯化的二苯乙烯苷提取物,加纯水Ⅰ溶解后冷冻结晶,待其融化后快速抽滤,并用纯水Ⅱ洗涤,可得类白色的结晶,将滤渣转移至真空干燥箱干燥,得二苯乙烯苷纯品。 The separation and purification process of stilbene glycosides, the specific steps are: accurately weigh the initially purified stilbene glycoside extract, add pure water I to dissolve it, freeze and crystallize it, and after it melts, quickly filter it and wash it with pure water II. Off-white crystals were obtained, and the filter residue was transferred to a vacuum oven for drying to obtain pure stilbene glycosides. the
优选的上述二苯乙烯苷的分离纯化工艺,所述初步纯化的二苯乙烯苷提取物与用于溶解提取物的纯水Ⅰ及用于洗涤结晶的纯水Ⅱ的重量:体积:体积按g/ml/ml计为1:3-7:3-7,冷冻结晶温度为-20±1℃-0±1℃。 The preferred separation and purification process of the above-mentioned stilbene glycosides, the weight of the preliminary purified stilbene glycoside extract and the pure water I used to dissolve the extract and the pure water II used to wash the crystals: volume: volume in g /ml/ml is calculated as 1:3-7:3-7, and the freezing and crystallization temperature is -20±1°C-0±1°C. the
优选的上述二苯乙烯苷的分离纯化工艺,所述初步纯化的二苯乙烯苷提取物与用于溶解提取物的纯水Ⅰ及用于洗涤结晶的纯水Ⅱ的重量:体积:体积按g/ml/ml计为1:3:5,冷冻结晶温度为-10℃±1℃。 The preferred separation and purification process of the above-mentioned stilbene glycosides, the weight of the preliminary purified stilbene glycoside extract and the pure water I used to dissolve the extract and the pure water II used to wash the crystals: volume: volume in g /ml/ml is calculated as 1:3:5, and the freezing and crystallization temperature is -10°C±1°C. the
优选的,上述二苯乙烯苷的分离纯化工艺,具体步骤如下: Preferably, the separation and purification process of the above-mentioned stilbene glycosides, the specific steps are as follows:
(1)称取二苯乙烯苷提取物,加甲醇或95%乙醇将其溶解后,加硅胶拌样,待溶剂挥发后研磨成松散状,其中,二苯乙烯苷提取物、甲醇或95%乙醇和硅胶的重量/体积/重量比按g/ml/g计为100:120-200:100-200; (1) Weigh the stilbene glycoside extract, add methanol or 95% ethanol to dissolve it, add silica gel to mix the sample, and grind it into a loose shape after the solvent evaporates. Among them, the stilbene glycoside extract, methanol or 95% The weight/volume/weight ratio of ethanol and silica gel is 100:120-200:100-200 in g/ml/g;
(2)将乙酸乙酯和硅胶按体积重量比ml/g计5:1进行混合,除去气泡后倾入玻璃柱中,并继续不断加入乙酸乙酯将附着于管壁的硅胶洗下,使玻璃柱表面硅胶平整; (2) Mix ethyl acetate and silica gel at a volume-to-weight ratio of 5:1 in ml/g, pour into a glass column after removing air bubbles, and continue to add ethyl acetate to wash off the silica gel attached to the tube wall, so that The silica gel on the surface of the glass column is smooth;
(3)将步骤(1)处理后的样品加至玻璃柱表层,开始用乙酸乙酯洗脱,经过TLC跟踪检测,合并含有二苯乙烯苷的流份,回收溶剂,干燥即得二苯乙烯苷提取物; (3) Add the sample treated in step (1) to the surface of the glass column, start to elute with ethyl acetate, track and detect by TLC, combine the fractions containing stilbene glycosides, recover the solvent, and dry to obtain stilbene Glycoside extract;
(4)精密称量初步纯化的二苯乙烯苷提取物,加纯水Ⅰ溶解后冷冻结晶,待其融化后快速抽滤,并用纯水Ⅱ洗涤,可得类白色的结晶,将滤渣转移至真空干燥箱干燥,得二苯乙烯苷纯品。 (4) Accurately weigh the preliminarily purified stilbene glycoside extract, add pure water I to dissolve it, and freeze it to crystallize it. After it melts, quickly filter it and wash it with pure water II to obtain off-white crystals. Transfer the filter residue to Dry in a vacuum oven to obtain pure stilbene glycosides. the
优选的,上述二苯乙烯苷的分离纯化工艺,所述步骤(4)中初步纯化的二苯乙烯苷提取物与用于溶解提取物的纯水Ⅰ及用于洗涤结晶的纯水Ⅱ的重量:体积:体积按g/ml/ml计为1:3-7:3-7,冷冻结晶温度为-20±1℃-0±1℃。 Preferably, the separation and purification process of the above-mentioned stilbene glycosides, the weight of the initially purified stilbene glycoside extract in the step (4) and the pure water I used to dissolve the extract and the pure water II used to wash the crystal : Volume: The volume is 1:3-7:3-7 in g/ml/ml, and the freezing and crystallization temperature is -20±1℃-0±1℃. the
优选的,上述二苯乙烯苷的分离纯化工艺,所述步骤(4)中初步纯化的二苯乙烯苷提取物与用于溶解提取物的纯水Ⅰ及用于洗涤结晶的纯水Ⅱ的重量:体积:体积按g/ml/ml计计为1:3:5,冷冻结晶温度为-10℃±1℃。 Preferably, the separation and purification process of the above-mentioned stilbene glycosides, the weight of the initially purified stilbene glycoside extract in the step (4) and the pure water I used to dissolve the extract and the pure water II used to wash the crystal : Volume: The volume is calculated in g/ml/ml as 1:3:5, and the freezing and crystallization temperature is -10℃±1℃. the
本发明的有益效果是: The beneficial effects of the present invention are:
上述二苯乙烯苷的分离纯化工艺,克服了现有自二苯乙烯苷提取物(何首乌提取物)中分离纯化二苯乙烯苷技术中存在的不足,操作简单可行,并可以提高产品纯度,能够快速大量地分离和纯化二苯乙烯苷;该工艺操作简便,无污染,成本低廉,收率稳定,在保持低成本和高收率的同时,经重结晶处理后能获得高纯度的二苯乙烯苷,且重复性好,适用性较广,纯度10%-80%的二苯乙烯苷样品都可以纯化至96%以上,适合规模化工业生产的需要。 The separation and purification process of the above-mentioned stilbene glycosides overcomes the deficiencies in the existing technology of separating and purifying stilbene glycosides from the extract of stilbene glycosides (polygonum multiflorum extract), the operation is simple and feasible, and the product purity can be improved. Rapidly separate and purify stilbene glycosides in large quantities; the process is simple to operate, pollution-free, low in cost, and stable in yield. While maintaining low cost and high yield, high-purity stilbene can be obtained after recrystallization Stilbene glycosides with good repeatability and wide applicability. Stilbene glycoside samples with a purity of 10%-80% can be purified to more than 96%, which is suitable for large-scale industrial production. the
附图说明 Description of drawings
图1是用3ml纯水溶解,-10℃±1℃中的条件冷冻结晶,用5ml的纯水洗涤得到的含量。 Figure 1 shows the content obtained by dissolving in 3ml of pure water, freezing and crystallizing at -10°C±1°C, and washing with 5ml of pure water. the
图2是用5ml纯水溶解,-10℃±1℃中的条件冷冻结晶,用5ml的纯水洗涤得到的含量。 Figure 2 shows the content obtained by dissolving with 5ml of pure water, freezing and crystallizing at -10°C±1°C, and washing with 5ml of pure water. the
图3是用7ml纯水溶解,-10℃±1℃中的条件冷冻结晶,用3ml的纯水洗涤得到的含量。 Figure 3 shows the content obtained by dissolving in 7ml of pure water, freezing and crystallizing at -10°C±1°C, and washing with 3ml of pure water. the
图4是用3ml纯水溶解,-10℃±1℃中的条件冷冻结晶,用7ml的纯水洗涤得到的含量。 Figure 4 shows the content obtained by dissolving with 3ml of pure water, freezing and crystallizing at -10°C±1°C, and washing with 7ml of pure water. the
图5是用3ml纯水溶解,0℃±1℃中的条件冷冻结晶,用3ml的纯水洗涤得到的含量。 Figure 5 shows the content obtained by dissolving in 3ml of pure water, freezing and crystallizing at 0°C±1°C, and washing with 3ml of pure water. the
图6是用5ml纯水溶解,0℃±1℃中的条件冷冻结晶,用7ml的纯水洗涤得到的含量。 Figure 6 shows the content obtained by dissolving with 5ml of pure water, freezing and crystallizing at 0°C±1°C, and washing with 7ml of pure water. the
图7是用7ml纯水溶解,0℃±1℃中的条件冷冻结晶,用5ml的纯水洗涤得到的含量。 Figure 7 shows the content obtained by dissolving in 7ml of pure water, freezing and crystallizing at 0°C±1°C, and washing with 5ml of pure water. the
图8是用7ml纯水溶解,-20℃±1℃中的条件冷冻结晶,用7ml的纯水洗涤得到的含量。 Figure 8 is the content obtained by dissolving with 7ml of pure water, freezing and crystallizing at -20°C±1°C, and washing with 7ml of pure water. the
图9是用3ml纯水溶解,-20℃±1℃中的条件冷冻结晶,用5ml的纯水洗涤得到的含量。 Figure 9 is the content obtained by dissolving with 3ml of pure water, freezing and crystallizing at -20°C±1°C, and washing with 5ml of pure water. the
图10是用5ml纯水溶解,-20℃±1℃中的条件冷冻结晶,用3ml的纯水洗涤得到的含量。 Figure 10 is the content obtained by dissolving with 5ml of pure water, freezing and crystallizing at -20°C±1°C, and washing with 3ml of pure water. the
图11是用二苯乙烯苷的提取物(二苯乙烯苷纯度50%)分离纯化二苯乙烯苷的HPLC检测图谱。 Fig. 11 is an HPLC detection spectrum for the separation and purification of stilbene glycosides using the extract of stilbene glycosides (50% purity of stilbene glycosides). the
图12是用二苯乙烯苷的提取物(80%)分离纯化二苯乙烯苷的HPLC检测图谱。 Fig. 12 is an HPLC detection spectrum of the separation and purification of stilbene glycosides with the extract of stilbene glycosides (80%). the
具体实施方式Detailed ways
为了使本领域的技术人员更好的理解本发明的技术方案,下面结合附图及具体实施方式对本发明所述技术方案作进一步的详细说明。 In order to enable those skilled in the art to better understand the technical solution of the present invention, the technical solution of the present invention will be further described in detail below in conjunction with the drawings and specific embodiments. the
以下实施例中的二苯乙烯苷提取物均为购自市场的何首乌提取物,经HPLC检测,上述二苯乙烯苷提取物中的二苯乙烯苷的纯度为10%-80%。通过下面的实施例用来说明本发明,但是不用来限制本发明的范围。本领域的专业人员能够理解,在不背离本发明的精神和范围的前提下,可以对本发明进行各种变化和修饰。本发明对试验中所使用到的材料以及试验方法进行一般性和/或具体的描述。虽然为实现本发明目的所使用的许多材料和操作方法是本领域公知的,但是本发明仍然在此作尽可能详细描述。在本发明中(除实施例1和2二苯乙烯苷纯品采用超高效液相色谱法检测,色谱柱:ACQUITY UPLC BEH C18(3.0×100mm,1.7μm);流动相:乙腈:水=10:90;流速:0.4mL/min;柱温:50℃;检测波长:320nm),其余检测提取物或单体成分所使用的HPLC方法为《中华人民共和国药典》关于何首乌中二苯乙烯苷的 测定方法,如下表所示。采用外标一点法测定其纯度。二苯乙烯苷对照品购于中国食品药品检定研究院,含量以94.7%计;批号:110844-201109;条形码:8EOS-NMAB。 The stilbene glycoside extracts in the following examples are all Polygonum multiflorum extracts purchased from the market, and the purity of the stilbene glycosides in the above stilbene glycoside extracts is 10%-80% as detected by HPLC. The present invention is illustrated by the following examples, but not intended to limit the scope of the present invention. Those skilled in the art can understand that various changes and modifications can be made to the present invention without departing from the spirit and scope of the present invention. The present invention provides general and/or specific descriptions of the materials and test methods used in the tests. While many of the materials and methods of manipulation which are employed for the purposes of the invention are well known in the art, the invention has been described here in as much detail as possible. In the present invention (except Examples 1 and 2, pure stilbene glycosides are detected by ultra-high performance liquid chromatography, chromatographic column: ACQUITY UPLC BEH C18 (3.0×100mm, 1.7 μm); mobile phase: acetonitrile: water=10 : 90; flow rate: 0.4mL/min; column temperature: 50°C; detection wavelength: 320nm), the HPLC method used for the remaining detection of extracts or monomer components is the "Pharmacopoeia of the People's Republic of China" on stilbene glycosides in Polygonum multiflorum The determination method is shown in the table below. The purity was determined by the external standard one-point method. The stilbene glycoside reference substance was purchased from China National Institutes for Food and Drug Control, with a content of 94.7%; batch number: 110844-201109; barcode: 8EOS-NMAB. the
色谱柱:Agilent Eclipse XDB-C18(4.6×150mm,5μm); Chromatographic column: Agilent Eclipse XDB-C18 (4.6×150mm, 5μm);
流动相:乙腈:水=18:82 Mobile phase: acetonitrile: water = 18:82
流速:1mL/min; Flow rate: 1mL/min;
柱温:20℃; Column temperature: 20°C;
检测波长:320nm; Detection wavelength: 320nm;
方法:以流动相(乙腈:水=18:82)等度洗脱,时间15min。 Method: Isocratic elution with mobile phase (acetonitrile: water = 18:82) for 15 minutes. the
实施例1 Example 1
用二苯乙烯苷的提取物(二苯乙烯苷纯度50%)分离纯化二苯乙烯苷,具体步骤如下: Use the extract of stilbene glycosides (50% purity of stilbene glycosides) to separate and purify stilbene glycosides, the specific steps are as follows:
(1)称取50%二苯乙烯苷提取物110g,置于烧杯中,加95%(v/v)乙醇150ml将其充分混合溶解后,加150g硅胶(200-300目)拌样,在通风橱里研磨并使溶剂自然挥干呈松散状; (1) Weigh 110g of 50% stilbene glycoside extract, put it in a beaker, add 150ml of 95% (v/v) ethanol to fully mix and dissolve it, add 150g of silica gel (200-300 mesh) to mix the sample, and put it in Grind in a fume hood and allow the solvent to evaporate naturally to become loose;
(2)将5000ml乙酸乙酯和1000g硅胶(100-200目)进行混合,搅拌以除去气泡,待浸泡完全后慢慢倾入玻璃柱中,然后继续加入乙酸乙酯,将附着于管壁的硅胶洗下,使玻璃柱表面硅胶平整; (2) Mix 5000ml of ethyl acetate and 1000g of silica gel (100-200 mesh), stir to remove air bubbles, slowly pour into the glass column after soaking completely, and then continue to add ethyl acetate to remove the Wash the silica gel to make the silica gel on the surface of the glass column smooth;
(3)将步骤(1)处理后的样品缓缓加在已制备好的玻璃柱上面,用乙酸乙酯洗脱,每600ml为1个流份,共收集20个流份,经过TLC跟踪检测,合并4~19,在365nm下可观察到蓝色荧光,合并含有二苯乙烯苷的流份,回收溶剂,干燥即得二苯乙烯苷的提取物; (3) Slowly add the sample treated in step (1) on the prepared glass column, elute with ethyl acetate, 1 fraction per 600ml, collect 20 fractions in total, and track and detect them by TLC , combined 4-19, blue fluorescence can be observed at 365nm, combined the fractions containing stilbene glycosides, recovered the solvent, and dried to obtain the extract of stilbene glycosides;
(4)精密称量初步纯化的二苯乙烯苷提取物约70g,置于烧杯中,用约3倍量(210ml)的纯水Ⅰ加热溶解后,置于-10℃±1℃的条件下冷冻至结晶后取出,待室温条件下溶化后转移至抽滤装置中抽滤,并用5倍量(350ml)的纯水Ⅱ少量分次洗涤,可见滤渣为类白色的结晶,将滤渣转移至真空干燥箱减压干燥即得二苯乙烯苷纯品41.78g,经HPLC检测,通过低温水媒法处理 后,二苯乙烯苷的纯度97.76%,结果见图11。 (4) Precisely weigh about 70g of the initially purified stilbene glycoside extract, put it in a beaker, heat and dissolve it with about 3 times the amount (210ml) of pure water I, and place it at -10°C±1°C Freeze until it crystallizes and take it out. After melting at room temperature, transfer it to a suction filtration device for suction filtration, and wash it with 5 times the amount (350ml) of pure water II in small amounts. It can be seen that the filter residue is off-white crystals, and the filter residue is transferred to a vacuum. After drying under reduced pressure in a drying oven, 41.78 g of pure stilbene glycosides were obtained. After HPLC detection and low-temperature water treatment, the purity of stilbene glycosides was 97.76%. The results are shown in Figure 11. the
实施例2 Example 2
用二苯乙烯苷的提取物(80%)分离纯化二苯乙烯苷,具体步骤如下: Use the extract of stilbene glycosides (80%) to separate and purify stilbene glycosides, the specific steps are as follows:
称量二苯乙烯苷样品(80%二苯乙烯苷的提取物)约70g,置于烧杯中,用约3倍量(210ml)的纯水Ⅰ加热溶解后,置于-10±1℃的条件下冷冻至结晶后取出,待室温条件下溶化后转移至抽滤装置中抽滤,并用5倍量(350ml)的纯水Ⅱ少量分次洗涤,可见滤渣为类白色的结晶,将滤渣转移至真空干燥箱减压干燥即得二苯乙烯苷纯品41.59g,经HPLC检测,通过低温水媒法处理后,二苯乙烯苷的纯度96.50%,结果见图12。 Weigh about 70g of the stilbene glycoside sample (80% stilbene glycoside extract), put it in a beaker, heat and dissolve it with about 3 times the amount (210ml) of pure water I, and place it in a -10±1°C Freeze until it crystallizes under certain conditions and take it out. After melting at room temperature, transfer it to a suction filtration device for suction filtration, and wash it with 5 times the amount (350ml) of pure water II in small amounts. It can be seen that the filter residue is off-white crystals. Transfer the filter residue After drying in a vacuum oven under reduced pressure, 41.59 g of pure stilbene glycosides were obtained. After HPLC detection and low-temperature water treatment, the purity of stilbene glycosides was 96.50%. The results are shown in Figure 12. the
实施例3 Example 3
用二苯乙烯苷的提取物(50%)分离纯化二苯乙烯苷,具体步骤如下: Use the extract of stilbene glycosides (50%) to separate and purify stilbene glycosides, the specific steps are as follows:
(1)称取50%二苯乙烯苷提取物100g,置于烧杯中,加120ml95%乙醇将其充分混合溶解后,加200g硅胶(200-300目)拌样,在通风橱里研磨并使溶剂自然挥干呈松散状; (1) Weigh 100g of 50% stilbene glycoside extract, put it in a beaker, add 120ml of 95% ethanol to mix and dissolve it, add 200g of silica gel (200-300 mesh) to mix the sample, grind it in a fume hood and make it The solvent evaporates naturally and becomes loose;
(2)将5000ml乙酸乙酯和1000g硅胶(100-200目)进行混合,搅拌以除去气泡,待浸泡完全后慢慢倾入玻璃柱中,然后继续加入乙酸乙酯,将附着于管壁的硅胶洗下,使玻璃柱表面硅胶平整; (2) Mix 5000ml of ethyl acetate and 1000g of silica gel (100-200 mesh), stir to remove air bubbles, slowly pour into the glass column after soaking completely, and then continue to add ethyl acetate to remove the Wash the silica gel to make the silica gel on the surface of the glass column smooth;
(3)将步骤(1)处理后的样品缓缓加在已制备好的玻璃柱上面,用乙酸乙酯洗脱,每600ml为1个流份,共收集20个流份,经过TLC跟踪检测,合并4~19,在365nm下可观察到蓝色荧光,合并含有二苯乙烯苷的流份,回收溶剂,干燥即得二苯乙烯苷的纯化粗品; (3) Slowly add the sample treated in step (1) on the prepared glass column, elute with ethyl acetate, 1 fraction per 600ml, collect 20 fractions in total, and track and detect them by TLC , combined 4-19, blue fluorescence can be observed at 365nm, combined the fractions containing stilbene glycosides, recovered the solvent, and dried to obtain the purified crude product of stilbene glycosides;
(4)精密称量初步纯化的二苯乙烯苷提取物约10g,置于烧杯中,用约5倍量(50ml)的纯水Ⅰ加热溶解后,置于-20℃±1℃的条件下冷冻至结晶后取出,待室温条件下溶化后转移至抽滤装置中抽滤,并用5倍量(50ml)的纯水Ⅱ少量分次洗涤,可见滤渣为类白色的结晶,将滤渣转移至真空干燥箱减压干燥即得二苯乙烯苷纯品7.53g,经HPLC检测,通过低温水媒法处理后,二苯乙烯苷的纯度91.7%。 (4) Precisely weigh about 10g of the initially purified stilbene glycoside extract, put it in a beaker, heat and dissolve it with about 5 times the amount (50ml) of pure water I, and place it at -20°C±1°C Freeze until it crystallizes and take it out. After melting at room temperature, transfer it to a suction filtration device for suction filtration, and wash it with 5 times the amount (50ml) of pure water II in small amounts. It can be seen that the filter residue is off-white crystals, and the filter residue is transferred to a vacuum. Drying in a drying oven under reduced pressure yielded 7.53 g of pure stilbene glycosides, which were detected by HPLC and treated by low-temperature water-medium method, and the purity of stilbene glycosides was 91.7%. the
实施例4 Example 4
用二苯乙烯苷的提取物(50%)分离纯化二苯乙烯苷,具体步骤如下: Use the extract of stilbene glycosides (50%) to separate and purify stilbene glycosides, the specific steps are as follows:
(1)称取50%二苯乙烯苷提取物100g,置于烧杯中,加200ml95%乙醇将其充分混合溶解后,加100g硅胶(200-300目)拌样,在通风橱里研磨并使溶剂自然挥干呈松散状; (1) Weigh 100g of 50% stilbene glycoside extract, put it in a beaker, add 200ml of 95% ethanol to mix and dissolve it, add 100g of silica gel (200-300 mesh) to mix the sample, grind it in a fume hood and make it The solvent evaporates naturally and becomes loose;
(2)将5000ml乙酸乙酯和1000g硅胶(100-200目)进行混合,搅拌以除去气泡,待浸泡完全后慢慢倾入玻璃柱中,然后继续加入乙酸乙酯,将附着于管壁的硅胶洗下,使玻璃柱表面硅胶平整; (2) Mix 5000ml of ethyl acetate and 1000g of silica gel (100-200 mesh), stir to remove air bubbles, slowly pour into the glass column after soaking completely, and then continue to add ethyl acetate to remove the Wash the silica gel to make the silica gel on the surface of the glass column smooth;
(3)将步骤(1)处理后的样品缓缓加在已制备好的玻璃柱上面,用乙酸乙酯洗脱,每600ml为1个流份,共收集20个流份,经过TLC跟踪检测,合并4~19,在365nm下可观察到蓝色荧光,合并含有二苯乙烯苷的流份,回收溶剂,干燥即得二苯乙烯苷的纯化粗品; (3) Slowly add the sample treated in step (1) on the prepared glass column, elute with ethyl acetate, 1 fraction per 600ml, collect 20 fractions in total, and track and detect them by TLC , combined 4-19, blue fluorescence can be observed at 365nm, combined the fractions containing stilbene glycosides, recovered the solvent, and dried to obtain the purified crude product of stilbene glycosides;
(4)精密称量初步纯化的二苯乙烯苷提取物约10g,置于烧杯中,用约4倍量(40ml)的纯水Ⅰ加热溶解后,置于-15℃±1℃的条件下冷冻至结晶后取出,待室温条件下溶化后转移至抽滤装置中抽滤,并用5倍量(50ml)的纯水Ⅱ少量分次洗涤,可见滤渣为类白色的结晶,将滤渣转移至真空干燥箱减压干燥即得二苯乙烯苷纯品7.47g,经HPLC检测,通过低温水媒法处理后,二苯乙烯苷的纯度94.32%。 (4) Precisely weigh about 10g of the initially purified stilbene glycoside extract, put it in a beaker, heat and dissolve it with about 4 times the amount (40ml) of pure water I, and place it at -15°C±1°C Freeze until it crystallizes and take it out. After melting at room temperature, transfer it to a suction filtration device for suction filtration, and wash it with 5 times the amount (50ml) of pure water II in small amounts. It can be seen that the filter residue is off-white crystals, and the filter residue is transferred to a vacuum. Drying in a drying oven under reduced pressure yielded 7.47 g of pure stilbene glycosides, which was detected by HPLC and treated by low-temperature water-medium method, and the purity of stilbene glycosides was 94.32%. the
工艺比较试验例 Process comparison test example
制备80%二苯乙烯苷含量的提取物:称取50%的二苯乙烯苷提取物约20g,采用硅胶柱层析的方法用乙酸乙酯等度洗脱,并根据薄层色谱跟踪检测,使二苯乙烯苷完全被洗脱,合并含二苯乙烯苷的洗脱液,回收溶解得到二苯乙烯苷样品粉末。以下试验均使用该样品粉末(二苯乙烯苷含量约80%)。 Preparation of an extract with 80% stilbene glycoside content: Weigh about 20 g of 50% stilbene glycoside extract, use silica gel column chromatography to elute isocratically with ethyl acetate, and track and detect according to thin-layer chromatography, The stilbene glycosides are completely eluted, the eluents containing the stilbene glycosides are combined, recovered and dissolved to obtain a stilbene glycoside sample powder. The sample powder (about 80% stilbene glycoside content) is used in the following tests. the
试验1:称取上述二苯乙烯苷样品约1.0g置于试管中,用3mL纯水加热溶解,使其在-10℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用5mL的纯水洗涤滤渣,所得固体干燥成粉末。经HPLC检测后,二苯乙烯苷的纯度96.72%,见图1。 Test 1: Weigh about 1.0g of the above-mentioned stilbene glycoside sample into a test tube, heat and dissolve with 3mL pure water, freeze and crystallize it at -10°C±1°C, take it out and wait for it to melt, and use a suction filtration device Suction filter, and wash the filter residue with 5 mL of pure water, and the obtained solid is dried into powder. After HPLC detection, the purity of stilbene glycosides was 96.72%, as shown in Figure 1. the
试验2:称取上述二苯乙烯苷样品约1.0g置于试管中,用5mL纯水加热溶解,使其在-10℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用5mL的纯水洗涤滤渣,所得固体干燥成粉末。经HPLC检测后,二苯乙烯苷的纯度为96.31%,见图2。 Test 2: Weigh about 1.0g of the above-mentioned stilbene glycoside sample into a test tube, heat and dissolve it with 5mL pure water, make it freeze and crystallize at -10°C±1°C, take it out and wait for it to melt, and use a suction filtration device Suction filter, and wash the filter residue with 5 mL of pure water, and the obtained solid is dried into powder. After HPLC detection, the purity of stilbene glycosides was 96.31%, as shown in Figure 2. the
试验3:称取上述二苯乙烯苷样品约1.0g置于试管中,用7mL纯水加热溶解,使其在-10℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用3mL的纯水洗涤滤渣,所得固体干燥成粉末。取样,用HPLC进行检测。经HPLC检测后,二苯乙烯苷的纯度为91.80%,见图3。 Test 3: Weigh about 1.0g of the above-mentioned stilbene glycoside sample into a test tube, heat and dissolve it with 7mL pure water, make it freeze and crystallize at -10°C±1°C, take it out and wait for it to melt, and use a suction filtration device Suction filter, and wash the filter residue with 3 mL of pure water, and the obtained solid is dried into powder. Samples were taken and detected by HPLC. After HPLC detection, the purity of stilbene glycosides was 91.80%, as shown in Figure 3. the
试验4:称取上述二苯乙烯苷样品约1.0g置于试管中,用3mL纯水加热溶解,并使其在-10℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用7mL的纯水洗涤滤渣,所得固体干燥成粉末。取样,经HPLC检测后,二苯乙烯苷的纯度为91.31%,见图4。 Test 4: Weigh about 1.0 g of the above-mentioned stilbene glycoside sample into a test tube, heat and dissolve with 3 mL of pure water, and make it freeze and crystallize at -10 °C ± 1 °C, take it out and wait for it to dissolve, and use suction filtration The device was suction filtered, and the filter residue was washed with 7 mL of pure water, and the obtained solid was dried into powder. Sampling, after HPLC detection, the purity of stilbene glycosides was 91.31%, as shown in Figure 4. the
试验5:称取上述二苯乙烯苷样品约1.0g置于试管中,用3mL纯水加热溶解,使其在0℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用3mL的纯水洗涤滤渣,所得固体干燥成粉末。取样,经HPLC检测后,二苯乙烯苷的纯度为93.83%,见图5。 Test 5: Weigh about 1.0 g of the above-mentioned stilbene glycoside sample into a test tube, heat and dissolve with 3 mL of pure water, freeze and crystallize it at 0°C±1°C, take it out and wait for it to dissolve, and use a suction filtration device to extract Filter, and wash the filter residue with 3 mL of pure water, and the obtained solid is dried into powder. Sampling, after HPLC detection, the purity of stilbene glycosides was 93.83%, as shown in Figure 5. the
试验6:称取上述二苯乙烯苷样品约1.0g置于试管中,用5mL纯水加热溶解,使其在0℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用7mL的纯水洗涤滤渣,所得固体干燥成粉末。取样,经HPLC检测后,二苯乙烯苷的纯度为93.36%,见图6。 Test 6: Weigh about 1.0 g of the above-mentioned stilbene glycoside sample and place it in a test tube, heat and dissolve it with 5 mL of pure water, make it freeze and crystallize at 0°C±1°C, take it out and wait for it to dissolve, and use a suction filtration device to extract Filter, and wash the filter residue with 7 mL of pure water, and the resulting solid is dried into powder. Sampling, after HPLC detection, the purity of stilbene glycosides was 93.36%, as shown in Figure 6. the
试验7:称取上述二苯乙烯苷样品约1.0g置于试管中,用7mL纯水加热溶解,使其在0℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用5ml的纯水洗涤滤渣,所得固体干燥成粉末。取样,经HPLC检测后,二苯乙烯苷的纯度为91.51%,见图7。 Test 7: Weigh about 1.0 g of the above-mentioned stilbene glycoside sample and place it in a test tube, heat and dissolve it with 7 mL of pure water, make it freeze and crystallize at 0°C±1°C, take it out to be melted, and use a suction filtration device to extract Filter, and wash the filter residue with 5ml of pure water, and the resulting solid is dried into powder. Sampling, after HPLC detection, the purity of stilbene glycosides was 91.51%, as shown in Figure 7. the
试验8:称取上述二苯乙烯苷样品约1.0g置于试管中,用7mL纯水加热 溶解,并使其在-20℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用7mL纯水洗涤滤渣,所得固体干燥成粉末。取样,经HPLC检测后,二苯乙烯苷的纯度为93.01%,见图8。 Test 8: Weigh about 1.0g of the above-mentioned stilbene glycoside sample into a test tube, heat to dissolve with 7mL of pure water, and make it freeze and crystallize at -20°C±1°C, take it out and wait for it to dissolve, and use suction filtration The device was suction filtered, and the filter residue was washed with 7 mL of pure water, and the obtained solid was dried into powder. Sampling, after HPLC detection, the purity of stilbene glycosides was 93.01%, as shown in Figure 8. the
试验9:称取上述二苯乙烯苷样品约1.0g置于试管中,用3mL纯水加热溶解,使其在-20℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用5mL的纯水洗涤滤渣,所得固体干燥成粉末。取样,经HPLC检测后,二苯乙烯苷的纯度为96.64%,见图9。 Test 9: Weigh about 1.0g of the above-mentioned stilbene glycoside sample into a test tube, heat and dissolve it with 3mL pure water, make it freeze and crystallize at -20°C±1°C, take it out and wait for it to dissolve, and use a suction filtration device Suction filter, and wash the filter residue with 5 mL of pure water, and the obtained solid is dried into powder. Sampling, after HPLC detection, the purity of stilbene glycosides was 96.64%, as shown in Figure 9. the
试验10:称取上述二苯乙烯苷样品约1.0g置于试管中,用5mL纯水加热溶解,并使其在-20℃±1℃中的条件冷冻结晶,取出待溶化后,采用抽滤装置抽滤,并用3mL的纯水洗涤滤渣,所得固体干燥成粉末。取样,经HPLC检测后,二苯乙烯苷的纯度为89.25%,见图10。 Test 10: Weigh about 1.0 g of the above-mentioned stilbene glycoside sample into a test tube, heat to dissolve with 5 mL of pure water, and make it freeze and crystallize at -20°C±1°C, take it out and wait for it to dissolve, and use suction filtration The device was filtered with suction, and the filter residue was washed with 3 mL of pure water, and the obtained solid was dried into powder. Sampling, after HPLC detection, the purity of stilbene glycosides was 89.25%, as shown in Figure 10. the
综上,通过试验1-10可以看出,本发明的分离纯化工艺中,每1.0g二苯乙烯苷样品使用溶媒(纯水)的体积是3ml,结晶温度是-10℃±1℃,洗涤体积是5ml时,效果更好。 In summary, it can be seen from Tests 1-10 that in the separation and purification process of the present invention, the volume of solvent (pure water) used per 1.0 g of stilbene glycoside sample is 3 ml, and the crystallization temperature is -10°C ± 1°C. The effect is better when the volume is 5ml. the
上述参照具体实施方式对该2,3,5,4′-四羟基二苯乙烯-2-O-β-D-葡萄糖苷的分离纯化工艺进行的详细描述,是说明性的而不是限定性的,可按照所限定范围列举出若干个实施例,因此在不脱离本发明总体构思下的变化和修改,应属本发明的保护范围之内。 The above detailed description of the separation and purification process of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside with reference to specific embodiments is illustrative rather than limiting , several embodiments can be listed according to the defined scope, so changes and modifications without departing from the general concept of the present invention should fall within the protection scope of the present invention. the
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310350567.7A CN103524576A (en) | 2013-08-12 | 2013-08-12 | Separation and purification process of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310350567.7A CN103524576A (en) | 2013-08-12 | 2013-08-12 | Separation and purification process of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103524576A true CN103524576A (en) | 2014-01-22 |
Family
ID=49926971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310350567.7A Pending CN103524576A (en) | 2013-08-12 | 2013-08-12 | Separation and purification process of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103524576A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105669791A (en) * | 2016-03-16 | 2016-06-15 | 中国人民解放军第四一一医院 | Method for using water as solvent to prepare stibene glucoside freeze-dried powder by utilizing polygonum multiflorum medicine material |
WO2016201953A1 (en) * | 2015-06-16 | 2016-12-22 | Rong-Tsun Wu | Method for treating or preventing dry eyes |
CN112521434A (en) * | 2020-12-07 | 2021-03-19 | 山东大学 | High-efficiency preparation method of stilbene glucoside in polygonum multiflorum |
CN112870979A (en) * | 2020-12-31 | 2021-06-01 | 内蒙古金达威药业有限公司 | Special membrane, preparation method and application thereof, and separation and purification method of beta-nicotinamide mononucleotide |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101255180A (en) * | 2007-02-27 | 2008-09-03 | 江苏正大天晴药业股份有限公司 | Diphenyl ethylene glycosides derivatives |
-
2013
- 2013-08-12 CN CN201310350567.7A patent/CN103524576A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101255180A (en) * | 2007-02-27 | 2008-09-03 | 江苏正大天晴药业股份有限公司 | Diphenyl ethylene glycosides derivatives |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016201953A1 (en) * | 2015-06-16 | 2016-12-22 | Rong-Tsun Wu | Method for treating or preventing dry eyes |
US10383885B2 (en) | 2015-06-16 | 2019-08-20 | Rong-Tsun Wu | Method for treating or preventing dry eyes |
CN105669791A (en) * | 2016-03-16 | 2016-06-15 | 中国人民解放军第四一一医院 | Method for using water as solvent to prepare stibene glucoside freeze-dried powder by utilizing polygonum multiflorum medicine material |
CN112521434A (en) * | 2020-12-07 | 2021-03-19 | 山东大学 | High-efficiency preparation method of stilbene glucoside in polygonum multiflorum |
CN112870979A (en) * | 2020-12-31 | 2021-06-01 | 内蒙古金达威药业有限公司 | Special membrane, preparation method and application thereof, and separation and purification method of beta-nicotinamide mononucleotide |
CN112870979B (en) * | 2020-12-31 | 2022-12-23 | 内蒙古金达威药业有限公司 | Separation and purification method of beta-nicotinamide mononucleotide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102584918B (en) | Method for preparing high-purity baicalin | |
CN102526315B (en) | Preparation method of extracts of effective fractions of lychee seeds | |
CN102973619B (en) | Process for extracting indoline amide alkaloid from purslane and detection methods for indoline amide alkaloid | |
CN102010316A (en) | Method for extracting high-purity frangula emodin from polygonum cuspidatum | |
CN101824018B (en) | Method for purifying dihydromyricetin | |
CN104327127B (en) | Method for preparing angroside C, aucubin and harpagide through separation and purification by high-speed countercurrent chromatography | |
CN103524576A (en) | Separation and purification process of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside | |
CN108864217A (en) | A kind of purification process of granatum punicalagins | |
CN104725450A (en) | Method for extracting high-purity oleuropein from jasminum grandiflorum | |
CN104147093A (en) | Method for rapidly extracting licorice flavonoids at room temperature | |
CN102924467B (en) | Preparation method for extracting and purifying bruceine D form brucea javanica | |
CN105440092B (en) | The fast preparation method of flavonoid glycoside in a kind of Extracted From Oil-tea-cake | |
CN102924537B (en) | Method for preparing hyperoside and isoquercitrin simultaneously from dogbane leaves | |
CN103408610B (en) | The method of arbutin is extracted from leaf of pear tree | |
CN104447910A (en) | Method for preparation of loganin from traditional Chinese medicine Cornus officinalis | |
CN102372754A (en) | Method for preparing specnuezhenide | |
CN102942611A (en) | Method for preparing high-purity siamenoside I | |
CN107298642B (en) | Extraction and purification method of 6-shogaol | |
CN103342689B (en) | Method for separation and purification of luteolin, apigenin and diosmetin in trichosanthes peel | |
CN103893236B (en) | Preparation method for concentrate of active substances in rape pollen | |
CN103304611B (en) | A kind of method of separation and purification 3 kinds of flavonoid glycosides from Snakegourd Peel | |
CN101538297A (en) | Preparation method of high-purity monomer flavone and general flavone contained in capsella bursa-pastoris and application of general flavone | |
CN109576048A (en) | The method extracted volatile oil from sunglo and extract sunglo polysaccharide and usnic acid simultaneously | |
CN109400665B (en) | Method for preparing four kinds of triterpenoid reference substances from holly vulgaris | |
CN101407536B (en) | Process for preparing high-purity asiaticoside by solvent crystallization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140122 |